Titan Medical Inc
TSX:TMD

Watchlist Manager
Titan Medical Inc Logo
Titan Medical Inc
TSX:TMD
Watchlist
Price: 0.045 CAD 2 268.42% Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Titan Medical Inc?
Write Note

Titan Medical Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Titan Medical Inc
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Titan Medical Inc
TSX:TMD
Cash from Financing Activities
-$580k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Profound Medical Corp
TSX:PRN
Cash from Financing Activities
$18.6m
CAGR 3-Years
13%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Opsens Inc
TSX:OPS
Cash from Financing Activities
CA$10.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
18%
Theralase Technologies Inc
XTSX:TLT
Cash from Financing Activities
CA$3.4m
CAGR 3-Years
N/A
CAGR 5-Years
-3%
CAGR 10-Years
-5%
MedMira Inc
XTSX:MIR
Cash from Financing Activities
CA$5.8m
CAGR 3-Years
246%
CAGR 5-Years
41%
CAGR 10-Years
2%
O
Ondine Biomedical Inc
LSE:OBI
Cash from Financing Activities
CA$3.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Titan Medical Inc
Glance View

Market Cap
1.1B CAD
Industry
Health Care

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). The company is headquartered in Toronto, Ontario and currently employs 49 full-time employees. The company went IPO on 2008-04-28. The firm is developing its Enos system to become the new standard of care in robotic single access surgery, with dual three-dimensional (3D) and two-dimensional (2D) high-definition vision systems, multi-articulating instruments and an ergonomic surgeon workstation. Its multi-articulated instruments bring fluid to position the effectors for grasping, suturing, cutting and coagulation. The Enos surgeon workstation includes a 3D high-definition display to provide a balance of surgical immersion and situational awareness in the operating room.

TMD Intrinsic Value
0.003 CAD
Overvaluation 93%
Intrinsic Value
Price

See Also

What is Titan Medical Inc's Cash from Financing Activities?
Cash from Financing Activities
-580k USD

Based on the financial report for Jun 30, 2024, Titan Medical Inc's Cash from Financing Activities amounts to -580k USD.

What is Titan Medical Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-54%

Over the last year, the Cash from Financing Activities growth was -54%.

Back to Top